Insider Transactions in Q2 2021 at Innoviva, Inc. (INVA)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 24
2021
|
George Bickerstaff Director |
BUY
Open market or private purchase
|
Direct |
10,000
+7.43%
|
$130,000
$13.46 P/Share
|
|
May 21
2021
|
George Bickerstaff Director |
BUY
Open market or private purchase
|
Direct |
10,000
+8.03%
|
$120,000
$12.97 P/Share
|
|
May 20
2021
|
Marianne Zhen Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
759
-1.89%
|
$9,867
$13.32 P/Share
|
|
May 20
2021
|
Glaxosmithkline PLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
32,005,260
-100.0%
|
$384,063,120
$12.25 P/Share
|
|
May 14
2021
|
Deborah Birx Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,482
+36.94%
|
-
|
|
May 14
2021
|
Sarah J. Schlesinger Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,482
+18.79%
|
-
|
|
May 14
2021
|
Mark Di Paolo Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,482
+18.79%
|
-
|
|
May 14
2021
|
Kostas D Odysseas Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,482
+18.01%
|
-
|
|
May 14
2021
|
George Bickerstaff Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,482
+14.32%
|
-
|
|
May 14
2021
|
Jules Haimovitz Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,482
+16.61%
|
-
|